logo
Plus   Neg
Share
Email

CMS Grants Addl Reimbursement For Boston Scientific's Eluvia Stent System - Quick Facts

Medical devices maker Boston Scientific Corp. (BSX) announced Thursday that the U.S. Centers for Medicare and Medicaid Services (CMS) granted a New Technology Add-on Payment (NTAP) for the Eluvia Drug-Eluting Vascular Stent System as part of the 2021 Inpatient Prospective Payment System (IPPS).

The Eluvia stent system was developed for the treatment of peripheral artery disease (PAD), which is the narrowing of the arteries of the legs due to plaque buildup. It affects approximately 8.5 million people in the United States and more than 200 million people worldwide.

The Eluvia stent re-opens the blocked artery and restores blood flow, while also utilizing a drug-polymer combination to offer a sustained, low-dose release of drug to prevent tissue regrowth within the stented artery.The FDA approved the Eluvia stent system in September 2018, based on findings from the IMPERIAL trial.

The NTAP designation, awarded to new medical devices determined to substantially improve the diagnosis or treatment of Medicare beneficiaries, will be effective on October 1, 2020. It will provide eligible hospitals with incremental reimbursement for the Eluvia stent system for up to three years.

The Medicare criteria for an NTAP designation is based on newness of the device, cost and a substantial clinical improvement.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The U.S. Food and Drug Administration (FDA) has gone ahead with the approval of antiviral drug remdesivir as first treatment for COVID-19, notwithstanding last week's findings by the World Health Organization (WHO) that the drug is not effective for COVID-19 treatment. Thursday, Gilead Sciences announced that the FDA approved remdesivir, sold under the brand name Veklury. Integrated payments firm American Express Co. (AXP) reported Friday that net income for the third quarter declined to $1.1 billion or $1.30 per share from $1.8 billion or $2.08 per share in the prior-year quarter. Consolidated total revenues, net of interest expense, also decreased 20 percent to $8.8... The Federal Trade Commission or FTC has launched a new fraud reporting platform, using which, consumers can easily report fraud and all other consumer issues directly to the regulator. In a statement, the FTC said its new website, ReportFraud.ftc.gov, will provide a streamlined and user-friendly way to submit reports about scams, frauds, and bad business practices.
Follow RTT